Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- We looked at Devoted's 2020 financial results;
- Scientists are working on a pan-coronavirus vaccine;
- Everything you need to know about biotech compensation.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Health insurance startup Devoted Health's losses are deepening as it takes on more members
- 2020 was a big year of revenue and membership growth for health insurance startup Devoted Health.
- Insider found Devoted grew revenue nearly fivefold to $227.2 million in 2020, topping projections.
- Still, Devoted's net loss widened to $73.3 million from $27.4 million in 2019.
Get the full annual financial results here>>
A promising new vaccine candidate could protect us from multiple coronaviruses – including some that haven't jumped to humans yet
- Researchers are working on a vaccine that could protect against multiple coronaviruses.
- A new study found the shot to be highly protective against current coronavirus variants in monkeys.
- The technology could help avoid a future of seasonal booster shots.
INSIDE BIOTECH: See the drug companies that are growing the fastest and pay workers the most
- Insider compiled data on the fastest-growing biotechs and pharmas, and what they're paying employees and executives.
- Hiring and retaining workers has been a challenge in the drug industry, leading to competitive pay packages.
- One company paid its median employee $701,000, while dozens of CEOs earned more than $18 million.
Here's a look at our coverage>>
More stories we're reading:
- How Dr. Ashish Jha became a ubiquitous presence in the pandemic (Stat News)
- A group of thousands of Japanese doctors want to cancel the Olympics as COVID-19 cases surge (Insider)
- HHS assistant secretary Rachel Levine lays out her priorities for the next few years (Bloomberg Law)
- I want to have kids but I worry about the impact on climate change. How can I move forward guilt-free? (Insider)
- Lydia
Read the original article on Business Insider